News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Casdin Capital, LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/02/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 08/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/11/2023 |
4
| Casdin Partners Master Fund, L.P. (10% Owner) has filed a Form 4 on BIOLIFE SOLUTIONS INC|
Txns:
| Bought 58,465 shares
@ $13.2001, valued at
$771.7k
|
|
| 05/23/2023 |
4
| Casdin Partners Master Fund, L.P. (10% Owner) has filed a Form 4 on BIOLIFE SOLUTIONS INC|
Txns:
| Bought 50,000 shares
@ $22.5486, valued at
$1.1M
Bought 24,973 shares
@ $21.8552, valued at
$545.8k
|
|
| 05/19/2023 |
4
| Casdin Partners Master Fund, L.P. (10% Owner) has filed a Form 4 on STANDARD BIOTOOLS INC.|
Txns:
| Bought 250,000 shares
@ $1.8862, valued at
$471.6k
Bought 150,000 shares
@ $2.1591, valued at
$323.9k
Bought 800,000 shares
@ $2.2949, valued at
$1.8M
|
|
| 05/19/2023 |
4/A
| Casdin Partners Master Fund, L.P. (10% Owner) has filed a Form 4 on BIOLIFE SOLUTIONS INC|
Txns:
| Acquired 131,428 shares
@ $0 |
|
| 05/18/2023 |
4
| Casdin Partners Master Fund, L.P. (10% Owner) has filed a Form 4 on BIOLIFE SOLUTIONS INC|
Txns:
| Bought 15,000 shares
@ $20.189, valued at
$302.8k
Bought 30,027 shares
@ $21.2957, valued at
$639.4k
Bought 30,000 shares
@ $21.7564, valued at
$652.7k
|
|
| 05/08/2023 |
SC 13D/A
| Casdin Capital, LLC reports a 4.8% stake in Absci Corporation |
| 03/20/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/13/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/10/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/10/2023 |
SC 13G/A
| Casdin Capital, LLC reports a 9% stake in MaxCyte, Inc. |
| 12/07/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 11/29/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 11/28/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 11/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 10/11/2022 |
SC 13D/A
| Casdin Capital, LLC reports a 5.5% stake in Century Therapeutics, Inc. |
| 10/05/2022 |
4
| Casdin Partners Master Fund, L.P. (10% Owner) has filed a Form 4 on MAXCYTE, INC.|
Txns:
| Sold 735,786 shares
@ $6.15, valued at
$4.5M
|
|
| 08/15/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 07/20/2022 |
SC 13D/A
| Casdin Capital, LLC reports a 8.3% stake in Absci Corporation |
| 07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/16/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 04/08/2022 |
SC 13D
| Casdin Capital, LLC reports a 32.7% stake in STANDARD BIOTOOLS INC. |
| 04/06/2022 |
4
| Casdin Partners Master Fund, L.P. (10% Owner) has filed a Form 4 on STANDARD BIOTOOLS INC.|
Txns:
| Granted 127,780 convertible preferred
@ $0 |
|
| 04/06/2022 |
3
| Casdin Partners Master Fund, L.P. (Director) has filed a Form 3 on STANDARD BIOTOOLS INC. |
| 02/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2022 |
SC 13G/A
| Casdin Capital, LLC reports a 6.5% stake in Verve Therapeutics, Inc. |
| 02/11/2022 |
SC 13G/A
| Casdin Capital, LLC reports a 6.6% stake in Magenta Therapeutics, Inc. |
| 02/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2022 |
SC 13G/A
| Casdin Capital, LLC reports a 5.4% stake in Invitae Corporation |
| 11/15/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/03/2021 |
4
| Casdin Partners Master Fund, L.P. (10% Owner) has filed a Form 4 on BIOLIFE SOLUTIONS INC|
Txns:
| Acquired 126,185 shares
@ $0 |
|
|
|
|